Doctor's Bio
Board Certifications
American Board of Urology
Affiliations
Emory
Education & Training
- Medical School: University of Chicago Pritzker School of Medicine
- Internship: University of California San Francisco School of Medicine
- Residency: University of California San Francisco School of Medicine
Fellowships
University of California San Francisco School of Medicine
Locations and Directions
Grady Memorial Hospital
Phone: (404) 616-1000
Location:
80 Jesse Hill Jr Drive SE
Atlanta, GA 30303
Publications
- Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell Carcinoma.
Goodstein T, Goradia R, Srivastava A, Sood A, Dason S, Master VA, Singer EA
Clinical genitourinary cancer. 2025;
PMID: 40962570 - Proposed tripartite classification of T1 renal cell carcinoma: Comparison with current binary system.
Meagher MF, Musso G, Master V, Tanaka H, Capitanio U, Larcher A, Dabbas M, Patil D, Chen W, Puri D, Baker BH, Imtiaz S, Saitta C, Fukuda S, Kobayashi M, Salonia A, Briganti A, Fujii Y, Montorsi F, Derweesh IH
Urologic oncology. 2025;
PMID: 40903318 - Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma-An Observational Prospective Multicentre Diagnostic Test Cohort Study.
Dabestani S, Azawi NH, Campi R, Järvinen P, Nisen H, Capitanio U, Nielsen TK, Simone G, Rochester M, Green E, Fernandez-Pello S, Blick C, Porpiglia F, Ingels A, Bratulic S, Antonelli A, Hakimi AA, Jewett MAS, Ljungberg B, Bhindi B, Marconi L, Laird A, Stewart GD, Nair R, Lund L, Barber N, Master VA, Minervini A, Karam JA, Gatto F, Bex A
European urology oncology. 2025;
PMID: 40866172 - Development of a Health-related Quality of Life Questionnaire for Patients with Metastatic or Localized Renal Cell Carcinoma.
Bergerot CD, Cella D, Bergerot PG, Castro DV, Mercier BD, Nally E, Ali AA, Philip EJ, Hutson T, Bex A, Psutka SP, Rini B, Plimack ER, Grünwald V, Master V, Albiges L, Choueiri TK, Pal SK, Powles T
European urology oncology. 2025;
PMID: 40829999 - Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank.
Shapiro DD, Abel EJ, Albiges L, Battle D, Berg SA, Campbell MT, Cella D, Coleman K, Garmezy B, Geynisman DM, Hall T, Henske EP, Jonasch E, Karam JA, La Rosa S, Leibovich BC, Maranchie JK, Master VA, Maughan BL, McGregor BA, Msaouel P, Pal SK, Perez J, Plimack ER, Psutka SP, Riaz IB, Rini BI, Shuch B, Simon MC, Singer EA, Smith A, Staehler M, Tang C, Tannir NM, Vaishampayan U, Voss MH, Zakharia Y, Zhang Q, Zhang T, Carlo MI
Urologic oncology. 2025;
PMID: 40820078 - Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete Metastasectomy.
Ghasemzadeh A, Abel EJ, Karam JA, Spiess PE, Peyton CC, Manley BJ, Sirard RB, Robertson N, Ellis EE, Cotta BH, Patel KR, Nicaise E, Jani A, Sexton WJ, Patil D, Allen GO, Matin SF, Master VA, Shapiro DD
The Journal of urology. 2025;
PMID: 40763351 - Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115).
Hamstra DA, Dignam JJ, Bruner DW, Michaelson MD, Bachand F, Master V, Torres MA, Saylor PJ, Wallace RE, Vapiwala N, Efstathiou JA, Roach M, Rosenthal SA, Raben A, Morgan SC, Kavadi VS, Spratt DE, Michalski JM, Seiferheld W, Pugh SL, Movsas B, Sandler H
International journal of radiation oncology, biology, physics. 2025;
PMID: 40712984 - Concordance between clinical and pathologic staging of larger (cT2a-b) and more invasive (cT3a) renal cell carcinoma.
Goodstein T, Goradia R, Srivastava A, Sood A, Dason S, Master VA, Singer EA
Urologic oncology. 2025;43(10):597.e5-597.e14.
PMID: 40603173 - Association of Elevated Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and De Ritis Ratios With Major Complications After Surgery for Renal Cell Carcinoma: A Pathway to Optimize Charlson Comorbidity Index and Preoperative Predictive Modeling.
Musso G, Birouty N, Salonia A, Garofano G, Dabbas M, Meagher MF, Yuen KL, Baker B, Saitta C, Patil D, Tanaka H, Kobayashi M, Fukuda S, Montorsi F, Briganti A, Capitanio U, Larcher A, Rosiello G, Fujii Y, Master VA, Derweesh IH
Urology. 2025;
PMID: 40578444 - Opioid Use in Patients With Testicular Cancer: Patterns and Risk Factors.
Marthi S, Palmateer G, Patil D, Helman TA, Nicaise E, Goodstein TA, Ogan K, Narayan VM, Master VA, Hajiha M, Joshi SS
Clinical genitourinary cancer. 2025;23(4):102381.
PMID: 40541494
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.